Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Journal of Cellular Physiology|April 30, 2016
Reprogramming for Cardiac Regeneration-Strategies for InnovationFabian Sanchis-Gomar, Teresa Galera, Alejandro Lucia, et al.Journal of Cellular Physiology|April 6, 2019
The mutation m.13513G>A impairs cardiac function, favoring a neuroectoderm commitment, in a mutant-load dependent wayTeresa Galera-Monge, Francisco Zurita-Díaz, Rafael Garesse, et al.Journal of Cellular and Molecular Medicine|April 2, 2019
iPSCs: A powerful tool for skeletal muscle tissue engineeringMaría Del Carmen Ortuño-Costela, Marta García-López, Victoria Cerrada, et al.Journal of Cellular Physiology|July 31, 2015
IPSCs, a Promising Tool to Restore Muscle AtrophyHelios Pareja-Galeano, Fabian Sanchis-Gomar, Enzo Emanuele, et al.Molecular Genetics & Genomic Medicine|April 2, 2014
The pathogenicity scoring system for mitochondrial tRNA mutations revisitedEmiliano González-Vioque, Belén Bornstein, María Esther Gallardo, et al.The Biochemical Journal|March 4, 2014
Glutamyl-tRNAGln amidotransferase is essential for mammalian mitochondrial translation in vivoLucía Echevarría, Paula Clemente, Rosana Hernández-Sierra, et al.Ageing Research Reviews|February 28, 2016
iPSCs-based anti-aging therapies: Recent discoveries and future challengesHelios Pareja-Galeano, Fabián Sanchis-Gomar, Laura M Pérez, et al.Oncotarget|March 28, 2020
Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutationsAlberto Cruz-Bermúdez, Carmen G Vallejo, Ramiro J Vicente-Blanco, et al.Oncotarget|April 25, 2015
Enhanced tumorigenicity by mitochondrial DNA mild mutationsAlberto Cruz-Bermúdez, Carmen G Vallejo, Ramiro J Vicente-Blanco, et al.Medicina Clinica|June 26, 2010
[Mitochondrial DNA depletion and POLG mutations in a patient with sensory ataxia, dysarthria and ophthalmoplegia]Ignacio J Posada, María Esther Gallardo, Cristina Domínguez, et al.Pageof 2